2.28
price up icon0.00%   0.00
 
loading
Schlusskurs vom Vortag:
$2.28
Offen:
$2.26
24-Stunden-Volumen:
70,328
Relative Volume:
0.32
Marktkapitalisierung:
$69.24M
Einnahmen:
$193.67M
Nettoeinkommen (Verlust:
$4.82M
KGV:
16.25
EPS:
0.1403
Netto-Cashflow:
$15.53M
1W Leistung:
-4.60%
1M Leistung:
-3.80%
6M Leistung:
-71.03%
1J Leistung:
-77.20%
1-Tages-Spanne:
Value
$2.215
$2.3097
1-Wochen-Bereich:
Value
$2.05
$2.445
52-Wochen-Spanne:
Value
$1.66
$10.62

Zynex Inc Stock (ZYXI) Company Profile

Name
Firmenname
Zynex Inc
Name
Telefon
(800)-495-6670
Name
Adresse
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Mitarbeiter
1,000
Name
Twitter
@zynexmedical
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
ZYXI's Discussions on Twitter

Vergleichen Sie ZYXI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
9.30 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.4126 530.67M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.22 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.08 138.66M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1602 343.88M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.16 0 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-12 Herabstufung Ladenburg Thalmann Buy → Neutral
2025-03-12 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2023-10-16 Eingeleitet RBC Capital Mkts Outperform
2023-01-06 Hochstufung Piper Sandler Neutral → Overweight
2022-02-28 Bestätigt B. Riley Securities Buy
2021-07-16 Hochstufung B. Riley Securities Neutral → Buy
2021-03-09 Hochstufung Northland Capital Market Perform → Outperform
2021-02-26 Herabstufung B. Riley Securities Buy → Neutral
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2021-01-28 Herabstufung Northland Capital Outperform → Market Perform
2020-09-14 Hochstufung H.C. Wainwright Neutral → Buy
2020-09-09 Hochstufung Northland Capital Market Perform → Outperform
2020-07-29 Hochstufung B. Riley FBR Neutral → Buy
2020-07-20 Eingeleitet Piper Sandler Overweight
2020-07-13 Herabstufung B. Riley FBR Buy → Neutral
2020-07-10 Bestätigt H.C. Wainwright Neutral
2020-06-16 Herabstufung Northland Capital Outperform → Market Perform
2020-05-19 Herabstufung H.C. Wainwright Buy → Neutral
2020-04-01 Eingeleitet Northland Capital Outperform
2019-09-23 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Zynex Inc Aktie (ZYXI) Neueste Nachrichten

pulisher
Jul 15, 2025

Royal Bank Of Canada Issues Pessimistic Forecast for Zynex (NASDAQ:ZYXI) Stock Price - MarketBeat

Jul 15, 2025
pulisher
Jul 15, 2025

Zynex (ZYXI) Target Price Lowered by RBC Capital, Maintains Rati - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

RBC Capital Downgrades Zynex to Sector Perform, PT to $3 from $4. - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Zynex stock price target lowered to $3 by RBC amid payment issues - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 12, 2025

Zynex: New CEO Steven Dyson shares his vision – ICYMI - Proactive financial news

Jul 12, 2025
pulisher
Jul 11, 2025

Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Execs Of Device Co. Made $6M From Insider Trading, Suit Says - Law360

Jul 10, 2025
pulisher
Jul 10, 2025

ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Zynex Shareholder Sues Board, Execs Over Insurer’s Payment Pause - Bloomberg Law News

Jul 10, 2025
pulisher
Jul 08, 2025

Zynex names Steven Dyson new CEO - ColoradoBiz

Jul 08, 2025
pulisher
Jul 08, 2025

Zynex appoints Steven Dyson as CEO; founder Thomas Sandgaard moves to Chairman role to steer vision - Proactive financial news

Jul 08, 2025
pulisher
Jul 05, 2025

Zynex CEO Thomas Sandgaard discusses leadership transitionICYMI - Proactive financial news

Jul 05, 2025
pulisher
Jul 03, 2025

Zynex confirms continued temporary payment suspension from Tricare - Proactive financial news

Jul 03, 2025
pulisher
Jul 03, 2025

Johnson Fistel, PLLP Investigates Telephone and Data - GlobeNewswire

Jul 03, 2025
pulisher
Jul 02, 2025

Zynex Says Tricare Payment Suspension Will Continue Amid Review - MarketScreener

Jul 02, 2025
pulisher
Jul 02, 2025

Zynex stock falls after Tricare extends payment suspension - Investing.com

Jul 02, 2025
pulisher
Jul 02, 2025

Zynex stock falls after Tricare extends payment suspension By Investing.com - Investing.com India

Jul 02, 2025
pulisher
Jul 02, 2025

Zynex, Inc. (ZYXI): Can Strategic Shifts and Liquidity Maneuvers Turn the Tide on Tricare's Stranglehold? - AInvest

Jul 02, 2025
pulisher
Jul 02, 2025

Tricare Temporary Payment Suspension Update - PR Newswire

Jul 02, 2025
pulisher
Jul 02, 2025

Medtech firm replacing CEO as it grapples with revenue loss, legal challenges - The Business Journals

Jul 02, 2025
pulisher
Jul 02, 2025

Zynex appoints Steven Dyson as CEO, founder Thomas Sandgaard transitions to Chairman role - Proactive financial news

Jul 02, 2025
pulisher
Jul 02, 2025

Zynex Appoints Steven Dyson as New CEO - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

H.C. Wainwright reiterates Buy rating on Zynex stock with $8 price target - Investing.com India

Jul 01, 2025
pulisher
Jun 30, 2025

Zynex Announces Steven Dyson as New CEO - GuruFocus

Jun 30, 2025
pulisher
Jun 30, 2025

Zynex taps Steve Dyson as chief executive officer - Proactive financial news

Jun 30, 2025
pulisher
Jun 30, 2025

Zynex, Inc.(NasdaqGS: ZYXI) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Zynex Announces Steven Dyson as New CEO | ZYXI Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 25, 2025

Zynex secures UK patent for noninvasive sepsis monitoring device - Investing.com

Jun 25, 2025
pulisher
Jun 25, 2025

Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis - PR Newswire

Jun 25, 2025
pulisher
Jun 25, 2025

Zynex awarded UK patent for non-invasive sepsis monitoring technology | NASDAQ:ZYXI - Proactive financial news

Jun 25, 2025
pulisher
Jun 25, 2025

Zynex Receives UK Patent for Noninvasive Sepsis Monitoring Device - MarketScreener

Jun 25, 2025
pulisher
Jun 24, 2025

Zynex Announces Workforce Reduction for Cost Savings - TipRanks

Jun 24, 2025
pulisher
Jun 24, 2025

Zynex Expects $5 Million In Annualized Cost Savings From Workforce ReductionSEC Filing - TradingView

Jun 24, 2025
pulisher
Jun 04, 2025

Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET - The Globe and Mail

Jun 04, 2025
pulisher
Jun 02, 2025

Two Sigma Advisers LP Sells 5,000 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Zynex, Inc.'s (NASDAQ:ZYXI) Shares Bounce 41% But Its Business Still Trails The Industry - simplywall.st

May 31, 2025
pulisher
May 29, 2025

Zynex, Inc. (NASDAQ:ZYXI) Shares Sold by BNP Paribas Financial Markets - Defense World

May 29, 2025
pulisher
May 29, 2025

Zynex (NASDAQ:ZYXI) Stock Price Down 3.9% – What’s Next? - Defense World

May 29, 2025
pulisher
May 28, 2025

Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing - openPR.com

May 28, 2025
pulisher
May 26, 2025

ZYXI LAWSUIT ALERT: The Gross Law Firm Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - cnhinews.com

May 26, 2025
pulisher
May 24, 2025

Zynex submits NiCO pulse oximeter technology for FDA clearanceICYMI - Proactive financial news

May 24, 2025
pulisher
May 23, 2025

Here’s Why Zynex (ZYXI) Fell in Q1 - Insider Monkey

May 23, 2025
pulisher
May 21, 2025

Zynex submits FDA application for NiCO, a breakthrough non-invasive co-oximeter - Proactive financial news

May 21, 2025
pulisher
May 20, 2025

Zynex, Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Zynex, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; May 19, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewswire Inc.

May 19, 2025
pulisher
May 19, 2025

ZYXI Deadline: ZYXI Investors with Losses in Excess of $100K Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit - marketscreener.com

May 19, 2025
pulisher
May 19, 2025

May 19, 2025 Deadline: Join Class Action Lawsuit Against Zynex, Inc. (ZYXI)Contact Levi & Korsinsky - ACCESS Newswire

May 19, 2025
pulisher
May 19, 2025

ZYXI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

ZYXI Investors Have Opportunity to Lead Zynex, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

May 19, 2025
pulisher
May 19, 2025

ZYXI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 19, 2025

Finanzdaten der Zynex Inc-Aktie (ZYXI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Zynex Inc-Aktie (ZYXI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Feb 03 '25
Sale
7.68
10,000
76,800
19,738
$1.4999
price up icon 2.03%
$2.065
price up icon 3.25%
medical_distribution YI
$7.50
price up icon 1.35%
medical_distribution OMI
$7.91
price up icon 1.65%
medical_distribution AHG
$1.7568
price up icon 8.84%
Kapitalisierung:     |  Volumen (24h):